Tag: Kadans Science Partner
Joint venture receives green light for Europe’s largest life sciences building
A joint centure between Canary Wharf Group (CWG) and Kadans Science Partner (Kadans) have secured planning approval from Tower Hamlets Council for the development...
Kadans adds Oxford asset to pan-European life science portfolio
Kadans Science Partner said it would acquire Harrow House, a purpose-built manufacturing facility in Oxford, UK, from Oxford Biomedica in a sale and lease...
Kadans expands life sciences portfolio with Oxford deal
Kadans Science Partner will expand its Pan-European life sciences portfolio by acquiring the freehold Windrush Innovation Centre in Oxford, UK, from Tozi Limited.
Kadans intends...
Plans submitted at Canary Wharf for Europe’s largest life sciences building
A joint venture between Canary Wharf Group (CWG) and Kadans Science Partner (Kadans) has submitted a detailed planning application for the 23-storey, 823,000 sq...
Kadans to develop life sciences innovation centre at Canary Wharf
Kadans Science Partner and Canary Wharf Group (CWG) are developing a new life sciences innovation centre at 20 Water Street in London.
Kadans will convert levels...
Kadans buys life sciences building in Oxford for £60m
Kadans Science Partner has agreed to acquire Windrush Court, a life sciences building in Oxford, UK, from Oxford Biomedica for £60 million in a...
Kadans, Canary Wharf to build Europe’s largest life science building
Kadans Science Partner and Canary Wharf Group have formed a joint venture to develop a new 750,000 sq ft GIA life science focused, wet...
Madison makes first investment in European life sciences sector
Madison International Realty has bought a minority stake in Kadans Science Partner through investment in AXA IM Alts' European Life Sciences platform.
Kadans Science...
AXA IM Alts raises €1.9bn to invest in European life sciences...
AXA IM Alts said Monday it has raised €1.9 billion of equity to accelerate investments into the European life sciences sector.
The capital was raised over...
AXA IM – Real Assets to enter European life science sector
AXA Investment Managers - Real Assets (AXA IM - Real Assets) is entering the European life science sector by acquiring Kadans Science Partner (Kadans)...
